GAITHERSBURG, Md.--(BUSINESS WIRE)--Aug. 10, 2006--Gene Logic Inc. (NASDAQ:GLGC) announced today that it entered into an agreement with the United States Food and Drug Administration (“FDA”) to provide the FDA with access to certain of Gene Logic’s genomics data and software, including:
